N-Nitroso-Moxonidine (mononitroso)

Status: Under Development

Moxonidine is used to decrease blood pressure and helps to prevent future stroke and heart attack.

Additional information on N-Nitroso-Moxonidine (mononitroso)

Catalogue No. VE007642
Molecular Formula C9H11ClN6O2
Molecular Weight 270.68 g/mol
Parent drug Moxonidine, Nitroso
IUPAC Name 4-chloro-6-methoxy-2-methyl-N-(1-nitroso-4, 5-dihydro-1H-imidazol-2-yl)-4, 5-dihydropyrimidin-5-amine
Synonyms N/A
References Sci-Hub, Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans, 10.1124/dmd.31.3.334. (2021). Retrieved December 1, 2021, from Hkvisa.net website: https://sci-hub.hkvisa.net/10.1124/dmd.31.3.334 Sci-Hub, Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON), 10.1016/S1388-9842(03)00163-6. (2021). Retrieved December 1, 2021, from Hkvisa.net website: https://sci-hub.hkvisa.net/10.1016/S1388-9
Status Under Development

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

N-Nitroso-Moxonidine (mononitroso)

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.